Aridis pharmaceuticals announces withdrawal of public offering of common stock

Los gatos, calif. , sept. 27, 2022 /prnewswire/ -- aridis pharmaceuticals, inc. (nasdaq: ards), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, today announced that due to adverse market conditions, it has withdrawn its proposed public offering of shares of its common stock.
ARDS Ratings Summary
ARDS Quant Ranking